Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- University of Maryland, Baltimore
- ;
- Duke University
- University of Glasgow
- University of London
- University of California, San Francisco
- University of Oxford
- Cornell University
- Emory University
- University of North Carolina at Chapel Hill
- Columbia University
- ISGLOBAL
- Lunds universitet
- Tulane University
- University of California
- University of Sheffield
- American Institutes for Research
- Boston College
- Case Western Reserve University
- Ehime University
- Fred Hutchinson Cancer Center
- Indiana University
- Instituto Gulbenkian de Ciência
- Johns Hopkins University
- KU Leuven
- Kanazawa University
- Karolinska Institutet
- La Trobe University
- Michigan State University
- Monash University
- Stanford University
- Temple University
- Umeå University
- University of Cambridge
- University of Hawaii John A Burns School of Medicine
- University of Illinois at Chicago
- University of Pennsylvania
- University of Utah
- University of Washington
- 29 more »
- « less
-
Field
-
., the principal vector of human malaria in sub-Saharan Africa and the mosquito, Aedes aegypti, which is the vector of dengue and Zika viruses and is an invasive mosquito species recently established in the state
-
of vector-borne diseases especially malaria. The Consortium partners are the London School of Hygiene & Tropical Medicine, the Centre for Research into Infectious Disease Cameroon, the Institut Pierre Richet
-
of vector-borne diseases especially malaria. One strand of our work concerns the arms race against insecticide resistance in African malaria vector mosquitoes, and in particular the process of choosing
-
Evaluation of the leukocyte contribution to innate immune responses to malaria vaccination
-
. We work to prevent and treat enteric and respiratory diseases, to reduce the threat of malaria and antimicrobial resistance, and to identify, understand, and combat other tropic and emerging pathogens
-
developed countries. We work to prevent and treat enteric and respiratory diseases, to reduce the threat of malaria and antimicrobial resistance, and to identify, understand, and combat other tropic and
-
clinical trials of investigational vaccines for SARS-CoV-2/COVID-19, HIV, malaria, tuberculosis (MTB), and Ebola. They will be responsible for performing and coordinating the assays with other technicians
-
malaria, as well as pain management and autoimmune disease with a focus on identifying optimal treatment regimens. We develop and apply disease models, perform pharmacokinetic and pharmacodynamic
-
to elucidate the mechanisms of humoral immune response to infection (HIV, SARS-CoV-2, influenza, malaria, etc.) and to understand the role and origin of autoreactive B cells in autoimmunity (systemic lupus
-
/logistics management systems, including inventory, storage, and distribution management, from the central warehouses to the last mile. A good understanding of HIV/AIDS, TB, malaria, and family planning